Safety and Efficacy of Dexamethasone as Adjunctive Therapy to Ranibizumab in Subjects With Choroidal Neovascularization and Age-Related Macular Degeneration
Clinical trial NCT01122511 · TERMINATED
Trial details
- NCT number
- NCT01122511
- Sponsor
- Allergan
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2011-05-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.